First patient treated
February 4, 2019 8:00 amin Redwood Pharma Phase II study
in Redwood Pharma Phase II study
Redwood Pharma receives its third and last national approval
from another drug authority – the Austrian
during Stora Aktiedagen Stockholm 2018
initiates clinical trial
on the way in the EU
2018
has submitted an application for the start of clinical trial
new rights issue oversubscribed
and takes important step in securing further financing